IN2013DN11328A - - Google Patents
Download PDFInfo
- Publication number
- IN2013DN11328A IN2013DN11328A IN11328DEN2013A IN2013DN11328A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A IN 11328DEN2013 A IN11328DEN2013 A IN 11328DEN2013A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A
- Authority
- IN
- India
- Prior art keywords
- turmerone
- disorders
- treatment
- turmeric oil
- abolene
- Prior art date
Links
- JIJQKFPGBBEJNF-UHFFFAOYSA-N curlone Chemical compound CC(C)=CC(=O)CC(C)C1CCC(=C)C=C1 JIJQKFPGBBEJNF-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000010681 turmeric oil Substances 0.000 abstract 2
- NAAJVHHFAXWBOK-ZDUSSCGKSA-N (+)-(S)-ar-turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CC=C(C)C=C1 NAAJVHHFAXWBOK-ZDUSSCGKSA-N 0.000 abstract 1
- XBGUIVFBMBVUEG-UHFFFAOYSA-N 1-methyl-4-(1,5-dimethyl-4-hexenylidene)-1-cyclohexene Chemical compound CC(C)=CCCC(C)=C1CCC(C)=CC1 XBGUIVFBMBVUEG-UHFFFAOYSA-N 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- JIJQKFPGBBEJNF-KBPBESRZSA-N Curlone Natural products CC(C)=CC(=O)C[C@H](C)[C@@H]1CCC(=C)C=C1 JIJQKFPGBBEJNF-KBPBESRZSA-N 0.000 abstract 1
- 206010044565 Tremor Diseases 0.000 abstract 1
- YHBUQBJHSRGZNF-HNNXBMFYSA-N alpha-bisabolene Natural products CC(C)=CCC=C(C)[C@@H]1CCC(C)=CC1 YHBUQBJHSRGZNF-HNNXBMFYSA-N 0.000 abstract 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 abstract 1
- XOCANRBEOZQNAQ-KGLIPLIRSA-N ar-turmerone Natural products C[C@H](CC(=O)C=C(C)C)[C@@H]1CC=C(C)C=C1 XOCANRBEOZQNAQ-KGLIPLIRSA-N 0.000 abstract 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 1
- 229930003493 bisabolene Natural products 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- OJEFBZMKKJTKKK-UHFFFAOYSA-N cis-alpha-Atlanton Natural products CC(C)=CC(=O)C=C(C)C1CCC(C)=CC1 OJEFBZMKKJTKKK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003179 convulsant agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- XOCANRBEOZQNAQ-UHFFFAOYSA-N α-turmerone Chemical compound CC(C)=CC(=O)CC(C)C1CC=C(C)C=C1 XOCANRBEOZQNAQ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1111319.8A GB201111319D0 (en) | 2011-07-04 | 2011-07-04 | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
| PCT/EP2012/063027 WO2013004740A1 (en) | 2011-07-04 | 2012-07-04 | Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013DN11328A true IN2013DN11328A (https=) | 2015-05-15 |
Family
ID=44512006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN11328DEN2013 IN2013DN11328A (https=) | 2011-07-04 | 2012-07-04 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9782361B2 (https=) |
| EP (1) | EP2729138B8 (https=) |
| JP (1) | JP6090867B2 (https=) |
| ES (1) | ES2661844T3 (https=) |
| GB (1) | GB201111319D0 (https=) |
| IN (1) | IN2013DN11328A (https=) |
| WO (1) | WO2013004740A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101517843B1 (ko) | 2013-09-30 | 2015-05-08 | 한국인스팜(주) | 울금 비극성용매 가용 추출물 또는 이로부터 분리된 아로매틱-튜메론을 유효성분으로 함유하는 스트레스관련 질환의 치료 및 예방을 위한 조성물 |
| JP6773361B2 (ja) * | 2015-04-09 | 2020-10-21 | ハウスウェルネスフーズ株式会社 | 気分状態改善剤 |
| JP6883845B2 (ja) * | 2017-03-17 | 2021-06-09 | 学校法人早稲田大学 | アストロサイト分化促進用組成物 |
| CN112351790A (zh) | 2018-06-29 | 2021-02-09 | 好侍健康食品株式会社 | 用于治疗、预防或改善阿尔茨海默氏症的组合物、用于抑制脑神经细胞死亡的组合物、用于抑制由β淀粉样蛋白诱导的小胶质细胞激活的组合物、及用于抑制由β淀粉样蛋白诱导的PGE2、TNF-α或IL-1β产生的组合物 |
| CN110721175A (zh) * | 2018-07-17 | 2020-01-24 | 文小燕 | 姜黄提取物在制备治疗癫痫的药物中的用途 |
| FR3098396B1 (fr) * | 2019-07-10 | 2022-07-29 | Indigo Therapeutics | Composition pour le traitement des troubles des émotions |
| CN113759007B (zh) * | 2020-08-25 | 2023-03-21 | 北京康仁堂药业有限公司 | 一种广西莪术的质量控制方法 |
| US20250195601A1 (en) * | 2023-12-18 | 2025-06-19 | Universidad De Cuenca | Turmeric oil essential-oil bisabolene sesquiterpenoids in the treatment of non-neurodegenerative diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA82057C2 (en) | 2001-12-14 | 2008-03-11 | Каунсил Оф Сайентифик Энд Индастриал Рисёрч | COMPOSITION basED on AR-D-turmeron and α- anD β-turmeron FOR TREATING NEUROCEREBROVASCULAR DISORDERS |
| US20040254146A1 (en) * | 2002-05-21 | 2004-12-16 | Nastech Pharmaceutical Company Inc. | Carboxylate salts of galantamine and their pharmaceutical use |
| JP2004331539A (ja) * | 2003-05-06 | 2004-11-25 | Maruzen Pharmaceut Co Ltd | 肝臓疾患予防治療剤及び肝臓疾患予防治療用飲食物 |
| CA2644093A1 (en) * | 2006-03-17 | 2007-09-27 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising curcuma species |
| CN101199833B (zh) | 2007-12-21 | 2011-03-16 | 北京中科雍和医药技术有限公司 | 一种缓解关节炎疼痛的复方精油 |
| TW201019949A (en) | 2008-10-16 | 2010-06-01 | Herbalscience Group Llc | Extracts of curcuma and methods of use thereof |
| RU2012107457A (ru) * | 2009-07-31 | 2013-09-10 | Когнишн Терапьютикс, Инк. | Ингибиторы ухудшения когнитивных способностей |
| WO2011080090A1 (en) | 2009-12-31 | 2011-07-07 | Arcelik Anonim Sirketi | A dishwasher comprising a microfilter |
| BR112012022983A2 (pt) | 2010-03-15 | 2015-09-15 | Laila Nutraceuticals | óleo de bosvélia, sua frações e composições para melhoria do funcionamento cerebral |
| PL2555787T3 (pl) | 2010-04-05 | 2018-04-30 | Benny Antony | Formulacja kurkuminy o zwiększonej biodostępności kurkuminy i sposób jej wytwarzania i traktowania |
-
2011
- 2011-07-04 GB GBGB1111319.8A patent/GB201111319D0/en not_active Ceased
-
2012
- 2012-07-04 WO PCT/EP2012/063027 patent/WO2013004740A1/en not_active Ceased
- 2012-07-04 IN IN11328DEN2013 patent/IN2013DN11328A/en unknown
- 2012-07-04 US US14/130,702 patent/US9782361B2/en not_active Expired - Fee Related
- 2012-07-04 JP JP2014517788A patent/JP6090867B2/ja active Active
- 2012-07-04 EP EP12735494.2A patent/EP2729138B8/en active Active
- 2012-07-04 ES ES12735494.2T patent/ES2661844T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9782361B2 (en) | 2017-10-10 |
| ES2661844T3 (es) | 2018-04-04 |
| JP6090867B2 (ja) | 2017-03-08 |
| EP2729138B1 (en) | 2017-12-13 |
| WO2013004740A1 (en) | 2013-01-10 |
| EP2729138A1 (en) | 2014-05-14 |
| EP2729138B8 (en) | 2018-02-28 |
| JP2014518241A (ja) | 2014-07-28 |
| GB201111319D0 (en) | 2011-08-17 |
| US20140243420A1 (en) | 2014-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013DN11328A (https=) | ||
| Ohno et al. | New insight into the therapeutic role of the serotonergic system in Parkinson's disease | |
| CL2015000096A1 (es) | Compuestos derivados de 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos, inhibidores de fosfodiestearasa 2 y/o 10; composicion farmaceutica; y su uso para prevencion o tratamiento de enfermedades del sistema nervioso, como deficiencia cognitiva, demencia, trastornos de ansiedad, enf. de alzheimer, enf. de parkinson, otros | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| GB201111712D0 (en) | Pharmaceutical compositions | |
| PH12014500472A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| GEP20186928B (en) | Binding molecules for bcma and cd3 | |
| EA201590655A8 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| PH12014502218A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
| PH12014500239A1 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| MY166890A (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| JOP20200041A1 (ar) | تركيبات صيدلية تحتوي على أجسام مضادة لبيتا نشوي | |
| BR112012009121A2 (pt) | Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central | |
| UA109260C2 (uk) | Хромонові похідні, спосіб їх одержання та їх терапевтичні застосування | |
| MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
| MX2021007142A (es) | Compuestos organicos. | |
| UA109414C2 (uk) | Арильовані камфени та фармацевтична композиція на їх основі | |
| WO2009151683A3 (en) | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications | |
| EP2542085A4 (en) | COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER | |
| IN2014DN10081A (https=) | ||
| MX2014010989A (es) | Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiatricos. | |
| MX343366B (es) | Peptidos de nd2 y metodos de tratamiento de enfermedad neurologica. | |
| MX2013011096A (es) | Metodos de tratamiento dirigido a degeneracion lobular frontotemporal. | |
| PH12015501109A1 (en) | Novel compounds as diacylglycerol acyltransferase inhibitors |